Power3
Amarantus Buys Power3's IP Portfolio for $40K
NEW YORK (GenomeWeb News) – Amarantus BioScience today announced it has acquired all the intellectual property assets from Power3 Medical Products for $40,000.
Based in The Woodlands, Texas, Power3 filed for Chapter 7 bankruptcy earlier this year.
Amarantus Licenses Power3 Test for Parkinson's Disease
NEW YORK (GenomeWeb News) – Amarantus BioSciences today said that it has licensed exclusive, worldwide rights from Power3 Medical Products to a test for Parkinson's disease diagnosis.
Power3 Buys Rozetta-Cell
Power3 will use Rozetta-Cell's stem cell technology with its own technology to develop screening and diagnostic tests.
Defendants Richard Kraniak and Roger Kazanowski argued that the company's complaint failed to "allege sufficient facts to state a claim for liability" under the Securities Exchange Act and the Securities Act, and failed to "plead with specificity necessary elements for these claims."